Certainty assessment

№ of patients

Effect

Certainty

Importance

№ of studies

Study design

Risk of bias

Inconsistency

Indirectness

Imprecision

Other considerations

ND0612

SoC oral Levodopa

Relative (95% CI)

Absolute (95% CI)

UPDRS Part III score (assessed with: MD)

3

randomised trials

very serious^a

Very serious^c

serious^b

very serious^b

publication bias strongly suspected^b

-

0 (0 to 0 )

⨁◯◯◯ Very low